News
The AMR Centre at Alderley Park has signed a co-development deal with a US biotech company.
The research and development facility, which specialises in antibiotics and diagnostics, has partnered with Massachusetts-based clinical-stage drug develo...
Manchester-based medtech company eLucid mHealth has secured investment from the GM&C Life Sciences Fund.
The fund, which is based in Alderley Park, is a seed and early-stage venture capital fund targeting life sciences businesses in the Great...
Blueberry Therapeutics Ltd is pleased to announce that it has taken a significant step forward in the development of new Acne treatments by gaining support from Innovate UK to co-fund critical research of this exciting programme. Principal Scienti...
Alderley Park, UK – 14 June 2017. Cytox, a leader in genetic testing for Alzheimer’s Disease, today announced that it has raised £2.6m to fund the commercial launch and international roll out of its novel service. The fundin...
CHARLOTTE, N.C.--(BUSINESS WIRE)--Tanner Pharma Group’s Managed Access Programs (MAP) division and Proveca have agreed to launch a Managed Access Program for an oral formulation of glycopyrronium (Sialanar®) outside Europe and the USA. S...